Story perspectives
Pfizer Building Structural Flaw Sparks Office-to-Housing Review
7/11/2026
1 of 1
Story summary
- A structural problem was reported at the Pfizer office building on 42nd Street and Second Avenue during its conversion to residential use.
- Engineer Guglielmo says the issue may stem from misunderstood design assumptions, construction errors, or overload, echoing experts who note adaptive-reuse of older office towers creates engineering and sustainability challenges.
- Joshua Harris warns the incident could prompt reviews of other office-to-housing conversions encouraged by zoning changes and tax incentives.
